{
}
UBS has maintained a 'Neutral' rating for Nokia, setting a price target of 3.55 euros following the company's third-quarter results, which fell short of sales expectations. While the operating result met forecasts due to a favorable product mix and cost-cutting, the analyst anticipates a slight decline in consensus estimates for the operating result due to more pessimistic annual targets.
The Italian pharmaceutical sector, particularly equivalent medicines, has saved the National Health Service approximately €6.25 billion since 2012, enhancing access to affordable care. Undersecretary Marcello Gemmato emphasized the need for supportive policies to foster innovation and investment, while addressing challenges like payback mechanisms that impact pharmaceutical companies. With a production value of €52 billion, Italy stands as a leader in European pharmaceutical innovation, crucial for both economic growth and public health advancements.
UBS has maintained a 'Neutral' rating for Nokia, setting a price target of 3.55 euros following the company's third-quarter results, which fell short of sales expectations. Despite this, the operating result aligned with forecasts due to effective cost management and product mix adjustments. Analysts anticipate a slight decline in consensus estimates for the operating result amid more cautious annual targets.
UBS has maintained a "Neutral" rating for Nokia with a target price of 3.55 euros following the company's third-quarter results, which fell short of sales expectations. Analyst Francois-Xavier Bouvignies noted that while the operating result met forecasts due to a favorable product mix and cost-cutting, the company's annual targets appear more pessimistic, suggesting a slight decline in consensus estimates for the operating result.
The European Central Bank has lowered the deposit rate to 3.25% and the refinancing rate to 3.40%, marking the third consecutive cut amid slowing inflation. In the US, retail sales rose by 0.4%, surpassing expectations, while initial jobless claims fell to 241,000, offering a glimmer of hope for the economy. Investors are eyeing the 19,700-point level on the DAX, with the 19,500-point mark as a key support.
UBS anticipates a quarter-point rate cut in December, reducing the main rate to 3%, with further cuts expected at each meeting until June. Investors are encouraged to consider investment-grade fixed income for higher yields, while small- and mid-cap stocks in Europe are seen as offering attractive value amid the anticipated rate reductions.
The global telemedicine market is projected to exceed USD 250 billion by 2029, growing at a CAGR of 17.22% from 2024 to 2029. Key drivers include increased adoption due to the pandemic, technological advancements, and the need for accessible healthcare, particularly in remote areas. However, challenges such as regulatory disparities and data privacy concerns persist across regions.
South Korea is exploring commercial satellite options for military communications due to budget constraints, while Poland is increasing space investments for security amid regional tensions. Nations like Senegal and Malaysia are developing their own space capabilities, emphasizing sovereignty and local expertise. France is also enhancing its space capabilities, contributing significantly to Europe's broadband constellation to ensure security and competitiveness.
UBS has maintained a 'Buy' rating for Sanofi, setting a target price of 110 euros ahead of the company's quarterly results due on October 25. Analyst Jo Walton highlighted the importance of the ongoing success of Dupixent and the market acceptance of Beyfortus.
UBS has reiterated a positive stock rating for Nordea Bank Abp, which operates across four main business areas: personal banking (38.9% of income), business banking (29.2%), institutional banking and large enterprises (20.2%), and asset and wealth management (11.7%). Geographically, the bank's income distribution is as follows: Finland (24.9%), Sweden (27.3%), Denmark (26.5%), Norway (17.5%), and other regions (3.8%).
Euro
Currency
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains neutral rating for nokia with target price of 3.55 euros
16:06 17.10.2024
Italy's pharmaceutical sector: balancing cost containment and sustainable growth
15:49 17.10.2024
ubs maintains neutral rating for nokia with target price of 3.55 euros
15:19 17.10.2024
UBS maintains neutral rating for Nokia after third quarter results
15:19 17.10.2024
ECB cuts deposit rate as retail sales and job claims improve
15:18 17.10.2024
ubs forecasts rate cuts through june boosting investment opportunities
14:40 17.10.2024
global telemedicine market poised for significant growth and innovation by 2029
Euro
United States Dollar
Teladoc Health, Inc.
RUS
DEU
ARG
USA
CAN
JPN
IND
ARE
MEX
COL
GBR
ZAF
AUS
ESP
KOR
BRA
SAU
CHN
ITA
Steven Thomas
Teladoc Health
Show more
14:32 17.10.2024
nations enhance space capabilities through commercial partnerships and sovereign initiatives
Euro
United States Dollar
Airbus SAS
Amazon.com, Inc.
OneWeb
FRA
PER
UKR
MYS
POL
SEN
KOR
Lionel Suchet
Mohd Fadzli Kamal
Aboubakar Mambimba Ndjoungui
Maram Kaire
Pacome Revillon
Show more
14:00 17.10.2024
ubs maintains buy rating for sanofi with target price of 110 euros
13:31 17.10.2024
ubs maintains positive outlook on nordea bank's diverse income streams
Euro
Swedish Krona
Danish Krone
United States Dollar
Norwegian Krone
Nordea Bank Abp
UBS SA
FIN
NOR
SWE
DNK
Show more
13:28 17.10.2024
Trending
Subcategory
Corporate News
Industry Trends
Stock Market Updates
Finance Mergers & Acquisitions
Retail and Consumer Goods
Global Financial Events
Market Analysis and Predictions
Banking Regulations
Industry Mergers & Acquisitions
CEO Changes
Global Trade Developments
Supply Chain Management
Workplace Trends
Startups & Entrepreneurship
Hedge Funds & Private Equity
Government Economic Policies
Central Bank Actions
Financial Scams and Security
Government Policies
Banking & Investment Regulations
Countries:
Companies:
Barclays PLC
BNP Paribas SA
Tesla, Inc.
Deutsche Bank RV Global PP
Raiffeisen Bank International AG
JPMorgan Chase & Co.
UniCredit S.p.A.
Apple Inc.
Strabag SE
Citigroup Inc.
Kering S.A. (ADRs)
The Goldman Sachs Group, Inc.
Banco BPM S.p.A.
UBS Group AG
Bank of America Corporation
Morgan Stanley
Berner Kantonalbank AG
Berkshire Hathaway Inc.
Microsoft Corporation
Google Inc.
Currencies:
United States Dollar
Euro
British Pound Sterling
Chinese Yuan
Swiss Franc
Japanese Yen
Indian Rupee
Vietnamese Đồng
Hong Kong Dollar
Australian Dollar
Russian Ruble
Brazilian Real
Filipino Peso
Malaysian Ringgit
United Arab Emirates Dirham
South African Rand
Indonesian Rupiah
South Korean Won
People: